See us at
V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER
MEDICA® 2021
ISSN 1068-1760
Hall 1-G59
I
N
Vol. 38 No.7 • 11/2021
T
Early Detection of Gastric Cancer
G
astric cancer (GC) is the fourth most-commonly diagnosed cancer, and the third leading cause of cancer-associated mortality worldwide. Despite improvements in treatment modalities, the prognosis for advanced GC following curative resection
E
E
R
N
A
T
I
DAILY CLINICAL LAB NEWS
®
O
Glial Fibrillary Acidic Protein Investigated as Stroke Biomarker
mergency medical services (EMS) encountering patients with acute stroke symptoms are challenged with the difficult task of rapidly triaging the patient to the appropriate hospital with sufficient therapeutic capabilities. Glial fibrillary acidic protein
Cont’d on page 10
(GFAP) and tau are differentially released in ischemic and hemorrhagic stroke (HS), but their very early release dynamics are unknown, as previous studies have focused on single-time point measurements after hospital admission. Circulating GFAP was Cont’d on page 12
Novel Probe Algorithm Detects Unknown Deadly Pathogens
N
A
L
Artificial Intelligence Identifies Leukemia
M
ulti-parameter flow cytometry (MFC) is a cornerstone in clinical decision making for leukemia and lymphoma. MFC data analysis requires manual gating of cell populations, which is time-consuming, subjective, and often limited to a two-dimensional space. Typical symptoms of malignant B-cell lymphomas and related leukemias are that the lymph nodes Cont’d on page 8
Biomarker for Dementia Diagnosis
A
biomarker panel based on five groups of metabolites was shown to be potentially useful for diagnosis and therapy of various forms of dementia, such as Alzheimer’s disease. Dementia, which is caused by factors that damage neurons, is characterized by a slowly progressing, chronic, and usually irreversible decline in cognitive function. The exact cause of
S
cientists have developed a sophisticated new diagnostic tool that provides early warnings on unknown viruses and identifies potentially deadly bacterial pathogens. See article on page 17
Cont’d on page 12 V
I
S
I
T
LINKXPRESS COM
R E A D E R
S E R V I C E
®
P O R T A L
Renew/Start your Free Subscription Access Interactive Digital Magazine Instant Online Product Information:
Rapid COVID-19 Variant Test Speeds Mutation Tracking from Weeks to Hours
E
fforts by researchers to identify and track variants of the SARS-CoV-2 virus has led to the creation and future implementation of a new method to “fingerprint” all currently known COVID-19 mutations. The method developed
LinkXpress codes of 1 Identify interest as you read magazine ®
on LinkXpress.com 2 toClick reach reader service portal Mark code(s) of interest on 3 LinkXpress inquiry matrix ®
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
A
Cont’d on page 8
Blood Lipid Biomarkers Linked to Lower Risk of ALS
myotrophic lateral sclerosis (ALS) ALS belongs to a wider group of disorders known as motor neuron diseases, which are caused by gradual deterioration (degeneration) and death of motor neurons. Motor neurons are nerve cells that extend from the brain to the spinal
cord and to muscles throughout the body. Premorbid body mass index, physical activity, diabetes and cardiovascular disease have been associated with an altered risk of developing amyotrophic lateral sclerosis (ALS). There is evidence of shared Cont’d on page 19
INSIDE
COVID-19 Update. . . . . 4 Clinical News. . . . . . . . . 8 IFCC News. . . . . . . . . . 29 Product News . . . . . 6-26 Industry News . . . . . . . 33 Events Calendar . . . . . 34
PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<